Sinocell Biotechnology Co., Ltd. is a biotechnology enterprise centered on cell-based medicine, dedicated to translating advanced cellular research into practical health management and medical solutions, and building a future-oriented longevity medicine and health security framework for individuals and families.

With core expertise in stem cells, immune cells, and cell-related technologies, Sinocell integrates premium health screening, functional assessment, cell preparation, cell cryopreservation, and research translation platforms, forming a complete closed-loop model covering assessment, intervention, storage, and long-term health management.

Supported by internationally aligned cell processing and research platforms, Sinocell provides professional, forward-looking, and sustainable cell medicine solutions, serving as a trusted partner in preventive health, longevity medicine, and future medical preparedness.

The Ningbo Regional Cell Preparation Center operates 12 GMP-compliant laboratories (B+A and C+A), built to international and national GMP standards with Class 100 cleanroom cell preparation processes. The center houses an AABB-standard integrated cell bank (Life Bank) and meets top regulatory requirements including EMA, FDA, CFDA, and GMP PIC/S across the Asia-Pacific region. Supported by a dedicated quality control system and digitalized management, the center serves as an advanced R&D platform focused on cellular biotechnology.